Back to results
US 8,709,446 B2Granted
HYR1 as a target for active and passive immunization against Candida
AssigneeLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
InventorsYue Fu, Guanpingsheng Luo, Ashraf Ibrahim, Brad Spellberg, John Edwards, Jr.
Life of this patent
Estimating the term…
Abstract
The invention features HYR1 as a vaccine target and as a prophylactic strategy for combating disseminated candidiasis.
Claims10
An immunogenic composition comprising an isolated polypeptide optionally fused to a heterologous fusion sequence and a pharmaceutically acceptable carrier, wherein the amino acid sequence of said polypeptide consists of the amino acid sequence of SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.